Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
GM2 accumulation in NP-C fibroblasts may inform pathogenesis models; leaves open therapeutic targeting pending in vivo validation.
Yano et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: